More specifically, our group has shown that the GLP-1R agonist liraglutide (LIR) delays the progression of diabetes, loss of vision and neurodegeneration and improves cognitive function in a rat model of WS [24,25,26,27]. The gene discussed is GLP1R; the disease is Werner syndrome.